Vitamin D: does it help Tregs in active rheumatoid arthritis patients

References

• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–38.
   PubMed Web of Science ®Google Scholar
• Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46:183–196.
   PubMed Web of Science ®Google Scholar
• Alunno A, Carubbi F, Giacomelli R, et al. Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets. BMC Rheumatol. 2017;1(1):3. .
   PubMedGoogle Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell. 2008;133:775–787.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chang C, Lu Q. Epigenetics of CD4+ T cells in autoimmune diseases. Curr Opin Rheumatol. 2017;29:361–368.
   PubMed Web of Science ®Google Scholar
• Tao JH, Cheng M, Tang JP, et al. Foxp3, regulatory T cell, and autoimmune diseases. Inflammation. 2017;40:328–339.
   PubMed Web of Science ®Google Scholar
• Takatori H, Kawashima H, Matsuki A, et al. Helios enhances Treg cell function in cooperation with FoxP3. Arthritis Rheumatol. 2015;67:1491–1502.
   PubMed Web of Science ®Google Scholar
• Lan Q, Fan H, Quesniaux V, et al. Induced Foxp3 (+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol. 2012;4:22–28.
   PubMed Web of Science ®Google Scholar
• Cooles FA, Isaacs JD, Anderson AE. Treg cells in rheumatoid arthritis: an update. Curr Rheumatol Rep. 2013;15:352.
   PubMed Web of Science ®Google Scholar
• Heidari B, Shirvani JS, Firouzjahi A, et al. Association between nonspecific skeletal pain and vitamin D deficiency. Int J Rheum Dis. 2010;13(4):340–346.
   PubMed Web of Science ®Google Scholar
• Rosen Y, Daich J, Soliman I, et al. Vitamin D and autoimmunity. Scand J Rheumatol. 2016;45(6):439–447.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Ann Rheum Dis. 2010 ;69:1580–1588.
   PubMed Web of Science ®Google Scholar
• Matsui T, Kuga Y, Kaneko A, et al. Disease activity score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis. 2007;66(9):1221–1226. .
   PubMed Web of Science ®Google Scholar
• Josefowicz SZ, Rudensky AY. Control of regulatory T cell lineage commitment and maintenance. Immunity. 2009;30:616–625.
   PubMed Web of Science ®Google Scholar
• Levesque R. SPSS Programming and Data Management: A Guide for SPSS and SAS Users (4th ed.). Chicago, Illinois: SPSS Inc; 2007.
   Google Scholar
• Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med. 2007;120(11):936–939.
   PubMed Web of Science ®Google Scholar
• Morgan ME, Flierman R, van Duivenvoorde LM, et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 2005;52:2212–2221.
   PubMed Web of Science ®Google Scholar
• Lee JH, Elly C, Park Y, et al. E3 ubiquitin ligase VHL regulates hypoxia-inducible factor-1α to maintain regulatory T cell stability and suppressive capacity. Immunity. 2015;42:1062–1074.
   PubMed Web of Science ®Google Scholar
• Byng-Maddick R, Ehrenstein MR. The impact of biological therapy on regulatory T cells in rheumatoid arthritis. Rheumatol (Oxford). 2015;54:768–775. .
   PubMed Web of Science ®Google Scholar
• Sempere-Ortells JM, Pérez-García V, Marín-Alberca G, et al. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28. Autoimmunity. 2009;42:636–645.
   PubMed Web of Science ®Google Scholar
• Li N, Ma T, Han J, et al. Increased apoptosis induction in CD4+ CD25+ Foxp3+ T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation. Eur Rev Med Pharmacol Sci. 2014;18:78–85.
   PubMed Web of Science ®Google Scholar
• Chavele KM, Ehrenstein MR. Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett. 2011;585:3603–3610.
   PubMed Web of Science ®Google Scholar
• Xiao H, Wang S, Miao R, et al. TRAIL is associated with impaired regulation of CD4+CD25- T cells by regulatory T cells in patients with rheumatoid arthritis. J Clin Immunol. 2011;31:1112–1119.
   PubMed Web of Science ®Google Scholar
• Walter GJ, Fleskens V, Frederiksen KS, et al. Phenotypic, functional, and gene expression profiling of peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127 (low) Treg cells in patients with chronic rheumatoid arthritis. Arthritis Rheumatol. 2016;68:103–116.
   PubMed Web of Science ®Google Scholar
• Van Amelsfort JM, Jacobs KM, Bijlsma JW, et al. CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004;50(9):2775–2785. .
   PubMed Web of Science ®Google Scholar
• Alunno A, Manetti M, Caterbi S, et al. Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications. Mediators Inflamm. 2015;2015:751793.
   PubMed Web of Science ®Google Scholar
• Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med. 2004;200:277–285.
   PubMed Web of Science ®Google Scholar
• Radnic T, Pasalic K, Bukilica MS, et al. SAT0028 peripheral blood regulatory T-lymphocytes of patients with rheumatoid arthritis before and after alfacalcidol therapy 2019;1078–1079.
   Google Scholar
• Bellan M, Andreoli L, Nerviani A, et al. Is cholecalciferol a potential disease modifying anti-rheumatic drug for the management of rheumatoid arthritis? Clin Exp Rheumatol. 2020 Mar-Apr;38(2):343–349.
   PubMed Web of Science ®Google Scholar
• Harrison SR, Li D, Jeffery LE, et al. Vitamin D, autoimmune disease and rheumatoid arthritis. Calcif Tissue Int. 2019;8:1–8.
   Google Scholar
• Meena N, Chawla SP, Garg R, et al. Assessment of vitamin D in rheumatoid arthritis and its correlation with disease activity. J Nat Sci Biol Med. 2018;9(1):54–58. .
   PubMedGoogle Scholar
• Elbassiony SR, Tawhid Z, Ahmad HS, et al. Serum 25-hydroxy vitamin D levels in Egyptian patients with rheumatoid arthritis: association with disease activity, functional disability and radiological damage. Egypt Rheumatol. 2016;38(3):133–139.
   Web of Science ®Google Scholar
• Chandrashekara S, Patted A. Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: an exploratory study. Int J Rheum Dis. 2017;20:825–831.
   PubMed Web of Science ®Google Scholar
• Adami G, Rossini M, Bogliolo L, et al. An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis. Mod Rheumatol. 2019 Nov 2;29(6):1059–1062.
   PubMed Web of Science ®Google Scholar
• Hansen KE, Bartels CM, Gangnon RE, et al. An evaluation of high-dose vitamin D for rheumatoid arthritis. J Clin Rheumatol. 2014;20:112–114.
   PubMed Web of Science ®Google Scholar
• Salesi M, Farajzadegan Z. Efficacy of vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy. Rheumatol Int. 2012;32:2129–2133.
   PubMed Web of Science ®Google Scholar
• Fisher SA, Rahimzadeh M, Brierley C, et al., The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: a systematic review. PloS One. 14(9): e0222313. 2019. .
   PubMed Web of Science ®Google Scholar
• Attar SM. Vitamin D deficiency in rheumatoid arthritis. Prevalence and association with disease activity in Western Saudi Arabia. Saudi Med J. 2012;33(5):520–525.
   PubMed Web of Science ®Google Scholar